Kirsty Winn is a cell biologist and pharmacologist experienced in early drug discovery and lead generation.
Kirsty joined MDC in 2020 as an External Drug Discovery Project Lead; responsible for providing drug discovery advice, scientific due diligence and robust research plans alongside UK medicines discovery innovators. Prior to MDC Kirsty led integrated drug discovery programmes for a large CRO, and before that worked for 15 years in large Pharma. As a leader in AstraZeneca’s Global HTS group, Kirsty was responsible for delivering hit generation strategies, assay and technology development and leading external alliances and innovation partnerships.
